Nifedipine Nitrosophenylpyridine Analog
United States Pharmacopeia (USP) Reference Standard
Manufacturer: Sigma Aldrich
CAS Number: 50428-14-3
Synonym(S): Dimethyl 2,6-dimethyl-4-(2-nitrosophenyl)-3,5-pyridinedicarboxylate
Select a Size
| Pack Size | SKU | Availability | Price |
|---|---|---|---|
| 25 MG | 1463701-25-MG | In Stock | ₹ 1,42,662.68 |
1463701 - 25 MG
In Stock
Quantity
1
Base Price: ₹ 1,42,662.68
GST (18%): ₹ 25,679.282
Total Price: ₹ 1,68,341.962
grade
pharmaceutical primary standard
API family
nifedipine
manufacturer/tradename
USP
application(s)
pharmaceutical (small molecule)
format
neat
SMILES string
O=C(OC)C1=C(C2=C(N=O)C=CC=C2)C(C(OC)=O)=C(C)N=C1C
InChI
1S/C17H16N2O5/c1-9-13(16(20)23-3)15(11-7-5-6-8-12(11)19-22)14(10(2)18-9)17(21)24-4/h5-8H,1-4H3
InChI key
MUZLTKGYFZENFW-UHFFFAOYSA-N
Other Options
| Image | Product Name | Manufacturer | Price Range | |
|---|---|---|---|---|
 | Sigma Aldrich Fine Chemicals Biosciences Nifedipine impurity B European Pharmacopoeia (EP) Reference Standard | 50428-14-3 | MFCD22572715 | | Sigma Aldrich Fine Chemicals Biosciences | ₹ 16,350.52 | |
 | Nifedipine impurity B | Sigma Aldrich | ₹ 14,267.35 | |
| | Dimethyl 2,6-dimethyl-4-(2-nitrosophenyl)-3,5-pyridinedicarboxylate | Sigma Aldrich | ₹ 21,401.03 | |
 | Dehydronitrosonifedipine | ChemScene | ₹ 33,282.84 | |
 | 50428-14-3 | 2,6-Ntp | A2B Chem | ₹ 97,367.28 |
Description
- General description: This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia.For further information and support please go to the website of the issuing Pharmacopoeia.
- Application: Nifedipine Nitrosophenylpyridine Analog USP reference standard, intended for use in specified quality tests and assays as specified in the USP compendia.
- Analysis Note: These products are for test and assay use only. They are not meant for administration to humans or animals and cannot be used to diagnose, treat, or cure diseases of any kind.
- Other Notes: Sales restrictions may apply.
SAFETY INFORMATION
Pictograms
Signal Word
Warning
Hazard Statements
Precautionary Statements
P261 - P264 - P270 - P301 + P312 - P302 + P352 - P305 + P351 + P338
Hazard Classifications
Acute Tox. 4 Oral - Eye Irrit. 2 - Skin Irrit. 2 - STOT SE 3
Target Organs
Respiratory system
WGK
WGK 3
Flash Point(F)
Not applicable
Flash Point(C)
Not applicable
Compare Similar Items
Show Difference
grade: pharmaceutical primary standard
API family: nifedipine
manufacturer/tradename: USP
application(s): pharmaceutical (small molecule)
format: neat
SMILES string: O=C(OC)C1=C(C2=C(N=O)C=CC=C2)C(C(OC)=O)=C(C)N=C1C
InChI: 1S/C17H16N2O5/c1-9-13(16(20)23-3)15(11-7-5-6-8-12(11)19-22)14(10(2)18-9)17(21)24-4/h5-8H,1-4H3
InChI key: MUZLTKGYFZENFW-UHFFFAOYSA-N
grade: pharmaceutical primary standard
API family: __
manufacturer/tradename: USP
application(s): pharmaceutical
format: neat
SMILES string: __
InChI: __
InChI key: __
grade: pharmaceutical primary standard
API family: nimodipine
manufacturer/tradename: USP
application(s): pharmaceutical (small molecule)
format: neat
SMILES string: COCCOC(=O)C1=C(C)NC(C)=C(C1c2cccc(c2)[N+]([O-])=O)C(=O)OC(C)C
InChI: 1S/C21H26N2O7/c1-12(2)30-21(25)18-14(4)22-13(3)17(20(24)29-10-9-28-5)19(18)15-7-6-8-16(11-15)23(26)27/h6-8,11-12,19,22H,9-10H2,1-5H3
InChI key: UIAGMCDKSXEBJQ-UHFFFAOYSA-N